Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Haematologica|February 2, 2023
Somatic genetic alterations predict hematological progression in GATA2 deficiencyLaetitia Largeaud, Matthew Collin, Nils Monselet, et al.
Bone Marrow Transplantation|July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMTSimona Iacobelli, Stefan Schönland, Linda Koster, et al.
Haematologica|March 23, 2023
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMTRaynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.
Bone Marrow Transplantation|December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyJesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2023
Genome-Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim-Chester DiseaseJavier Martínez-López, Ana Márquez, Francesco Pegoraro, et al.
Blood Advances|January 28, 2026
Pregnancy after Haematopoietic Stem Cell Transplant: an international multicentre studyNina Salooja, Dirk-Jan Eikema, David Michonneau, et al.
Transplantation and Cellular Therapy|October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Haematologica|June 30, 2022
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelingSarah Lawless, Simona Iacobelli, Nina Simone Knelange, et al.
Blood|April 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMTJuan Montoro, Dirk-Jan Eikema, Joe Tuffnell, et al.
Pageof 15